Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Long Term Safety Study of Apricitabine in HIV-infected Patients

This study has been withdrawn prior to enrollment.
(Study was withdrawn owing to Sponsor decision)
Sponsor:
Information provided by:
Avexa
ClinicalTrials.gov Identifier:
NCT00686270
First received: May 27, 2008
Last updated: June 22, 2011
Last verified: June 2011
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: May 2012
  Estimated Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)